MEDS - Rasio utang marang kapitalisasi buku TRxADE

Logo grafis trxadehealth.com (MEDS)

Geopolitical tensions and data localization requirements are hindering the expansion of the TRxADE HEALTH, Inc. (MEDS) digital pharmacy network into global markets. Meanwhile, the B2B platform for independent pharmacists serves as a cash cow, generating steady cash flow due to user preference for a single-window procurement system. The debt-to-capitalization ratio on the balance sheet reflects the impact of optimizing wholesale transactions, where the value of 0.00 corresponds to the current metric.

TRxADE Health Corp (MEDS) - Utang-utang marang nilai buku saka 04.07.2022 nganti 28.10.2026
Produk mawa merek TRxADE

Investors must filter out illiquid assets based on strict financial stability criteria. This ratio compares total debt to balance sheet equity, determining the degree of debt load on equity. For TRxADE HEALTH (MEDS), with its weak pricing power and dumping resulting from a model shift, this risk is critical. An analysis of the changing proportion of total debt to balance sheet capitalization reveals dangerous leverage zones. Breaking outside the corridor boundaries signals a threat of default.

Pesaing TRxADE HEALTH, Inc.

Utang marang nilai buku Veeva Systems Inc.|doximity.com - Rasio utang marang aset resik|HQY: Rasio utang marang kapitalisasi buku|WAY - Utang marang nilai buku|Utang-utang marang kapitalisasi buku CRVL|Privia Medical Group (PRVA) - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku Huron Consulting Group (HURN)|Rasio utang marang nilai buku certara.com (CERT)|Utang marang nilai buku Omnicell|Utang marang modal buku GDRX (GoodRx Inc)|Rasio utang marang kapitalisasi buku Schrödinger Inc.|PHR - Rasio utang marang aset resik|Omada Health Inc (OMDA) - Utang marang nilai buku|EVH - Rasio utang marang nilai buku|HSTM: Utang-utang marang kapitalisasi buku|Definitive Healthcare Corp (DH) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku Consensus (CCSI)|Rasio utang marang nilai buku Agilon Health Corp|Absci - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku soyoung.com SY|Utang marang nilai buku National Research Corp|Rasio utang marang aset resik Spok Holdings Inc SPOK|Utang-utang marang kapitalisasi buku OptimizeRx Corp. (OPRX)|TBRG - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku SLP|SOPHiA GENETICS (SOPH) - Utang-utang marang nilai buku|HCAT (Health Catalyst) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku CCLD|Rasio utang marang kapitalisasi buku Research Solutions (RSSS)|Rasio utang marang kapitalisasi buku dlhcorp.com DLHC|Utang marang nilai buku OneMedNet (ONMD)|Utang marang modal buku scienture.com SCNX|Utang-utang marang kapitalisasi buku Healthcare Triangle, Inc. (HCTI)|iSpecimen Inc. (ISPC) - Rasio utang marang aset resik|Utang marang nilai buku bullfrogai.com BFRG|SCWorx Inc (WORX) - Rasio utang marang aset resik|MSPR: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik ICCT|Rasio utang marang kapitalisasi buku Orgenesis ORGS|Rasio utang marang nilai buku r1rcm.com (RCM)|Sharecare, Inc - Utang-utang marang kapitalisasi buku|STRM - Utang marang nilai buku|Utang marang nilai buku SYRA (Syra Health Corp.)|AMEH: Utang-utang marang aset resik|MODN (Model N) - Rasio utang marang kapitalisasi buku|NextGen Healthcare Inc (NXGN) - Utang marang nilai buku